FDA expands Approval of Tirbanibulin for Actinic Keratosis on Larger Areas of Face and Scalp Dr. Kamal Kant Kohli11 Jun 2024 9:00 PM ISTAlmirall, a global pharmaceutical company dedicated to medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has...
Pitavastatin may suppress skin and pancreatic cancers by blocking inflammatory protein, indicates study Dr. Kamal Kant Kohli11 Jun 2024 8:30 AM ISTA new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that...
Researchers develop microneedle patch to reverse hair loss caused by autoimmune disease Dr. Kamal Kant Kohli10 Jun 2024 8:00 AM ISTAlopecia areata (AA) is an autoimmune disease characterized by hair loss, which occurs when T cells of the immune system mistakenly attack hair...
Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases: JAMA Dr. Kamal Kant Kohli7 Jun 2024 8:00 PM ISTA drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no...
Can high sodium diet increase risk of eczema? Dr. Kamal Kant Kohli6 Jun 2024 9:00 PM ISTUCSF Study finds that changes in daily salt intake may explain eczema flares. A high sodium diet may increase the risk of eczema, according to...
Topical STS-01 Hits Efficacy Endpoints in Mild to Moderate Alopecia patients in Phase 2 trial Dr. Kamal Kant Kohli5 Jun 2024 8:00 PM ISTSoterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its randomised,...
Donidalorsen Therapy Effective Against Hereditary Angioedema: NEJM Written By Jacinthlyn Sylvia5 Jun 2024 6:30 AM ISTA recent phase published in the New England Journal of Medicine 3 trial demonstrated that donidalorsen, an antisense oligonucleotide, significantly...
Upadacitinib Outperforms Dupilumab in Treating Atopic Dermatitis: Study Written By Dr Riya Dave4 Jun 2024 8:00 PM ISTResearchers have found that upadacitinib (Rinvoq) was more effective than dupilumab (Dupixent) in treating moderate-to-severe atopic dermatitis in a...
Sun Pharma, Philogen seek EMA marketing nod for skin cancer treatment Nidlegy Written By Ruchika Sharma4 Jun 2024 4:45 PM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced the submission of a Marketing Authorization Application (MAA)...
Preoperative washing with chlorhexidine gluconate and postoperative occlusion reduces postoperative wound infections: Study Written By Jacinthlyn Sylvia3 Jun 2024 8:30 PM ISTA recent study found promising results in preventing infections in lower extremity surgical sites after Mohs micrographic surgery. The research...
Study Explores Unreported Allergic Contact Dermatitis due to Salicylic Acid Written By Jacinthlyn Sylvia2 Jun 2024 8:00 PM ISTA recent study from a dermatology clinic, published in the recent issue of Contact Dermatitis journal highlighted the underreported issue of allergic...
Results of Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024 Written By Ruchika Sharma1 Jun 2024 11:30 AM ISTMumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced that the primary results of the Nidlegy Phase III PIVOTAL...
